Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Initiation
Charlotte's Web initiated with an Outperform at Cowen » 05:56
06/12/20
06/12
05:56
06/12/20
05:56
CWBHF

Charlotte's Web

$0.00 /

+ (+0.00%)

Cowen analyst Gerald…

Cowen analyst Gerald Pascarelli initiated coverage of Charlotte's Web with an Outperform rating and $7 price target.

ShowHide Related Items >><<
CWBHF Charlotte's Web
$0.00 /

+ (+0.00%)

CWBHF Charlotte's Web
$0.00 /

+ (+0.00%)

03/23/20 Canaccord
Charlotte's Web price target lowered to C$10 from C$17 at Canaccord
03/09/20 Cantor Fitzgerald
Charlotte's Web price target lowered to $7 from $11.70 at Cantor Fitzgerald
12/09/19 Compass Point
Compass Point starts Charlotte's Web at Buy with $12 price target
12/09/19 Compass Point
Charlotte's Web initiated with a Buy at Compass Point
CWBHF Charlotte's Web
$0.00 /

+ (+0.00%)

On The Fly
Rising High: HEXO Q3 net revenue increases 30% sequentially to C$22.1M » 10:45
06/11/20
06/11
10:45
06/11/20
10:45
HEXO

Hexo

$1.07 /

+0.045 (+4.41%)

, OGI

Organigram

$2.01 /

-0.18 (-8.22%)

, CWBHF

Charlotte's Web

$0.00 /

+ (+0.00%)

, ABAHF

Abacus Health Products

$0.00 /

+ (+0.00%)

, SHWZ

Schwazze

$0.00 /

+ (+0.00%)

, CGC

Canopy Growth

$16.52 /

-1.18 (-6.67%)

, APHA

Aphria

$4.51 /

-0.405 (-8.25%)

, ACV

Alberto-Culver

$23.19 /

-0.63 (-2.64%)

, CVSI

CV Sciences

$0.00 /

+ (+0.00%)

, CTST

CannTrust

$0.64 /

+ (+0.00%)

, CRON

Cronos Group

$6.70 /

-0.89 (-11.73%)

, CANN

General Cannabis

$0.00 /

+ (+0.00%)

, IGC

India Globalization Capital

$0.62 /

-0.0043 (-0.69%)

, TLRY

Tilray

$8.97 /

-0.71 (-7.33%)

, TCNNF

Trulieve Cannabis

$0.00 /

+ (+0.00%)

, ZYNE

Zynerba

$4.88 /

-0.3 (-5.79%)

In this week's "Rising…

Open Full Text

ShowHide Related Items >><<
ZYNE Zynerba
$4.88 /

-0.3 (-5.79%)

TLRY Tilray
$8.97 /

-0.71 (-7.33%)

TCNNF Trulieve Cannabis
$0.00 /

+ (+0.00%)

OGI Organigram
$2.01 /

-0.18 (-8.22%)

IGC India Globalization Capital
$0.62 /

-0.0043 (-0.69%)

HEXO Hexo
$1.07 /

+0.045 (+4.41%)

CWBHF Charlotte's Web
$0.00 /

+ (+0.00%)

CVSI CV Sciences
$0.00 /

+ (+0.00%)

CTST CannTrust
$0.64 /

+ (+0.00%)

CRON Cronos Group
$6.70 /

-0.89 (-11.73%)

CGC Canopy Growth
$16.52 /

-1.18 (-6.67%)

CANN General Cannabis
$0.00 /

+ (+0.00%)

APHA Aphria
$4.51 /

-0.405 (-8.25%)

HEXO Hexo
$1.07 /

+0.045 (+4.41%)

06/11/20 Alliance Global Partners
Hexo continues to make strides in right direction, says Alliance Global Partners
04/15/20 Alliance Global Partners
Hexo price target lowered to C$1.50 from C$2.50 at Alliance Global Partners
03/31/20
Fly Intel: Top five analyst downgrades
03/31/20 BofA
Hexo resumed with an Underperform at BofA
OGI Organigram
$2.01 /

-0.18 (-8.22%)

04/15/20 CIBC
Organigram downgraded to Neutral from Outperformer at CIBC
04/01/20 Cantor Fitzgerald
Organigram price target lowered to C$5.80 from C$9.00 at Cantor Fitzgerald
03/19/20 BofA
Organigram upgraded to Neutral from Underperform at BofA
01/15/20
Fly Intel: Top five analyst upgrades
CWBHF Charlotte's Web
$0.00 /

+ (+0.00%)

03/23/20 Canaccord
Charlotte's Web price target lowered to C$10 from C$17 at Canaccord
03/09/20 Cantor Fitzgerald
Charlotte's Web price target lowered to $7 from $11.70 at Cantor Fitzgerald
12/09/19 Compass Point
Compass Point starts Charlotte's Web at Buy with $12 price target
12/09/19 Compass Point
Charlotte's Web initiated with a Buy at Compass Point
ABAHF Abacus Health Products
$0.00 /

+ (+0.00%)

SHWZ Schwazze
$0.00 /

+ (+0.00%)

CGC Canopy Growth
$16.52 /

-1.18 (-6.67%)

06/01/20 Canaccord
Canopy Growth price target lowered to C$21 from C$23 at Canaccord
06/01/20 Scotiabank
Canopy Growth price target lowered to C$28 from C$33 at Scotiabank
06/01/20 Ladenburg
Canopy Growth downgraded to Neutral from Buy at Ladenburg
06/01/20
Fly Intel: Top five analyst downgrades
APHA Aphria
$4.51 /

-0.405 (-8.25%)

05/13/20 Cantor Fitzgerald
Aphria price target lowered to C$9.55 from C$9.85 at Cantor Fitzgerald
04/16/20 CIBC
Aphria price target lowered to C$6 from C$7 at CIBC
04/16/20 Canaccord
Aphria strong adult-use growth well-above expectations, says Canaccord
04/15/20 Alliance Global Partners
Aphria price target lowered to C$9 from C$11 at Alliance Global Partners
ACV Alberto-Culver
$23.19 /

-0.63 (-2.64%)

CVSI CV Sciences
$0.00 /

+ (+0.00%)

04/08/20 Raymond James
Ontario AG order positive for Canadian cannabis stocks, says Raymond James
04/07/20 Cantor Fitzgerald
CV Sciences a takeover target after patent approval, says Cantor Fitzgerald
03/17/20 Roth Capital
CV Sciences downgraded to Neutral from Buy at Roth Capital
03/09/20 Cantor Fitzgerald
CV Sciences price target lowered to $1.60 from $4.20 at Cantor Fitzgerald
CTST CannTrust
$0.64 /

+ (+0.00%)

07/12/19
CannTrust downgraded to Sell from Neutral at Eight Capital
07/09/19 Roth Capital
CannTrust downgraded to Neutral from Buy at Roth Capital
07/08/19
CannTrust downgraded to Neutral from Buy at Eight Capital
07/08/19 BofA
BofA double downgrades CannTrust to Underperform after Health Canada probe
CRON Cronos Group
$6.70 /

-0.89 (-11.73%)

04/27/20 Raymond James
Cronos Group downgraded to Market Perform from Outperform at Raymond James
04/14/20 Piper Sandler
Piper Sandler downgrades Cronos to Neutral on delayed CBD launch
04/13/20 Piper Sandler
Cronos Group downgraded to Neutral from Overweight at Piper Sandler
CANN General Cannabis
$0.00 /

+ (+0.00%)

11/05/19 BofA
BofA says Mexico cannabis legalization 'still in play' in 2020 after extension
10/10/19 Stifel
Hexo miss further damages cannabis industry credibility, says Stifel
09/26/19 Compass Point
Cannabis banking bill should find path to passage in Senate, says Compass Point
IGC India Globalization Capital
$0.62 /

-0.0043 (-0.69%)

TLRY Tilray
$8.97 /

-0.71 (-7.33%)

05/27/20 Roth Capital
Roth Capital sees Tilray operational moves as 'positive'
05/19/20 MKM Partners
Tilray price target raised to $8 from $5 at MKM Partners
05/12/20 Alliance Global Partners
Tilray price target lowered to $9 from $15 at Alliance Global Partners
05/12/20 Stifel
Tilray price target raised to $6.50 from $5.50 at Stifel
TCNNF Trulieve Cannabis
$0.00 /

+ (+0.00%)

04/06/20 Cantor Fitzgerald
Trulieve Cannabis price target raised to $32 from $30 at Cantor Fitzgerald
02/14/20 Cantor Fitzgerald
Cantor initiates 10 cannabis names, sees opportunity after sellofff
02/13/20 Cantor Fitzgerald
Trulieve Cannabis initiated with an Overweight at Cantor Fitzgerald
ZYNE Zynerba
$4.88 /

-0.3 (-5.79%)

05/28/20 Cantor Fitzgerald
Zynerba price target raised to $24 from $21 at Cantor Fitzgerald
05/27/20 Roth Capital
Roth Capital raises Zynerba target to $11 on positive autism data
05/22/20 Cantor Fitzgerald
Zynerba price target raised to $21 from $12 at Cantor Fitzgerald
ZYNE Zynerba
$4.88 /

-0.3 (-5.79%)

TLRY Tilray
$8.97 /

-0.71 (-7.33%)

OGI Organigram
$2.01 /

-0.18 (-8.22%)

HEXO Hexo
$1.07 /

+0.045 (+4.41%)

CVSI CV Sciences
$0.00 /

+ (+0.00%)

CRON Cronos Group
$6.70 /

-0.89 (-11.73%)

CGC Canopy Growth
$16.52 /

-1.18 (-6.67%)

APHA Aphria
$4.51 /

-0.405 (-8.25%)

CVSI CV Sciences
$0.00 /

+ (+0.00%)

CTST CannTrust
$0.64 /

+ (+0.00%)

CGC Canopy Growth
$16.52 /

-1.18 (-6.67%)

APHA Aphria
$4.51 /

-0.405 (-8.25%)

SHWZ Schwazze
$0.00 /

+ (+0.00%)

OGI Organigram
$2.01 /

-0.18 (-8.22%)

HEXO Hexo
$1.07 /

+0.045 (+4.41%)

CGC Canopy Growth
$16.52 /

-1.18 (-6.67%)

APHA Aphria
$4.51 /

-0.405 (-8.25%)

TLRY Tilray
$8.97 /

-0.71 (-7.33%)

OGI Organigram
$2.01 /

-0.18 (-8.22%)

HEXO Hexo
$1.07 /

+0.045 (+4.41%)

CTST CannTrust
$0.64 /

+ (+0.00%)

CRON Cronos Group
$6.70 /

-0.89 (-11.73%)

CGC Canopy Growth
$16.52 /

-1.18 (-6.67%)

APHA Aphria
$4.51 /

-0.405 (-8.25%)

Hot Stocks
Charlotte's Web acquires Abacus Health Products » 10:18
06/11/20
06/11
10:18
06/11/20
10:18
CWBHF

Charlotte's Web

$0.00 /

+ (+0.00%)

, ABAHF

Abacus Health Products

$0.00 /

+ (+0.00%)

Charlotte's Web…

Charlotte's Web Holdings (CWBHF) and Abacus Health Products (ABAHF) announced that they have completed the previously-announced plan of arrangement. Pursuant to the Arrangement, Charlotte's Web acquired all the issued and outstanding subordinate voting shares of Abacus. All the outstanding proportionate voting shares of Abacus were converted into Abacus Shares prior to closing of the Arrangement. Pursuant to the Arrangement, holders of Abacus Shares received 0.85 of a common share of Charlotte's Web for each Abacus Share held at the time of closing. Combined, the companies distribute to more than 21,000 unique retail locations with limited shelf overlap due to adjacent but complementary positions across the ingestible and topical CBD product categories. Recently Charlotte's Web added 1,100 new drug stores, more than 700 pet stores, and Abacus added more than 5,000 retail doors with the signing of a new retail partner. Joining the Charlotte's Web family of brands are Abacus' consumer brands CBD MEDIC and Harmony Hemp, and for professional practitioners, Abacus' CBD CLINIC brand. Substantial product cross selling opportunities are available through each company's respective distribution network. Starting in July, multiple Abacus topical products will be available for purchase through Charlotte's Web's leading Direct to the Consumer ecommerce platform. Perry Antelman has been the CEO of Abacus since 2016 and will join Charlotte's Web as EVP and President of Topicals. Following the closing of this acquisition, on June 11, 2020, Charlotte's Web has 90,287,520 Common Shares outstanding and 92,455.5775 Proportionate Voting Shares convertible at 400:1, for an effective equivalent of 127,269,751 aggregate Common Shares outstanding.

ShowHide Related Items >><<
CWBHF Charlotte's Web
$0.00 /

+ (+0.00%)

CWBHF Charlotte's Web
$0.00 /

+ (+0.00%)

03/23/20 Canaccord
Charlotte's Web price target lowered to C$10 from C$17 at Canaccord
03/09/20 Cantor Fitzgerald
Charlotte's Web price target lowered to $7 from $11.70 at Cantor Fitzgerald
12/09/19 Compass Point
Compass Point starts Charlotte's Web at Buy with $12 price target
12/09/19 Compass Point
Charlotte's Web initiated with a Buy at Compass Point
ABAHF Abacus Health Products
$0.00 /

+ (+0.00%)

Hot Stocks
Charlotte's Web earns U.S. utility patent for hemp variety » 10:31
05/20/20
05/20
10:31
05/20/20
10:31
CWBHF

Charlotte's Web

$0.00 /

+ (+0.00%)

Charlotte's Web has…

Charlotte's Web has earned U.S. utility patent U.S. 10,653,085, its second U.S. patent for hemp genetics. This patent is for 'CW1AS1', a new hemp variety created by company co-founder Joel Stanley and Sr. Director of Cultivation R&D Bear Reel.

ShowHide Related Items >><<
CWBHF Charlotte's Web
$0.00 /

+ (+0.00%)

03/23/20 Canaccord
Charlotte's Web price target lowered to C$10 from C$17 at Canaccord
03/09/20 Cantor Fitzgerald
Charlotte's Web price target lowered to $7 from $11.70 at Cantor Fitzgerald
12/09/19 Compass Point
Compass Point starts Charlotte's Web at Buy with $12 price target
12/09/19 Compass Point
Charlotte's Web initiated with a Buy at Compass Point
Over a quarter ago
Recommendations
Charlotte's Web price target lowered to C$10 from C$17 at Canaccord » 11:01
03/23/20
03/23
11:01
03/23/20
11:01
CWBHF

Charlotte's Web

$0.00 /

+ (+0.00%)

Canaccord analyst Derek…

Canaccord analyst Derek Dley lowered the firm's price target on Charlotte's Web to C$10 from C$17 and keeps a Buy rating on the shares, ahead of the company's earnings report scheduled for March 24.

ShowHide Related Items >><<
CWBHF Charlotte's Web
$0.00 /

+ (+0.00%)

03/09/20 Cantor Fitzgerald
Charlotte's Web price target lowered to $7 from $11.70 at Cantor Fitzgerald
12/09/19 Compass Point
Compass Point starts Charlotte's Web at Buy with $12 price target
12/09/19 Compass Point
Charlotte's Web initiated with a Buy at Compass Point
11/07/19 Cantor Fitzgerald
Cantor Fitzgerald expects industry consolidation in consumer CBD wellness trend
Recommendations
Charlotte's Web price target lowered to $7 from $11.70 at Cantor Fitzgerald » 07:13
03/09/20
03/09
07:13
03/09/20
07:13
CWBHF

Charlotte's Web

$0.00 /

+ (+0.00%)

Cantor Fitzgerald analyst…

Cantor Fitzgerald analyst Pablo Zuanic lowered the firm's price target on Charlotte's Web to $7 from $11.70 and keeps a Neutral rating on the shares. The continued lack of clear guidelines for cannabidiol from the FDA limits the scope for new distribution gains in the food, drug and mass channel, while increased hemp supplies further "clog the specialty channel with a slew of new brands," Zuanic tells investors in a research note.

ShowHide Related Items >><<
CWBHF Charlotte's Web
$0.00 /

+ (+0.00%)

12/09/19 Compass Point
Compass Point starts Charlotte's Web at Buy with $12 price target
12/09/19 Compass Point
Charlotte's Web initiated with a Buy at Compass Point
11/07/19 Cantor Fitzgerald
Cantor Fitzgerald expects industry consolidation in consumer CBD wellness trend
11/07/19 Cantor Fitzgerald
Charlotte's Web initiated with a Neutral at Cantor Fitzgerald
Initiation
Compass Point starts Charlotte's Web at Buy with $12 price target » 08:29
12/09/19
12/09
08:29
12/09/19
08:29
CWBHF

Charlotte's Web

$0.00 /

+ (+0.00%)

As previously reported,…

As previously reported, Compass Point analyst Rommel Dionisio initiated coverage of Charlotte's Web with a Buy rating and $12 price target. A longer than expected delay in the U.S. FDA issuing regulatory guidelines for the introduction of CBD-infused edibles and beverages has pressured shares, but he sees Charlotte's Web being the best positioned company to benefit from what should be significant growth in the CBD industry for many years to come given position as a pure play with the number one brand of cannabidiol infused products in the U.S.

ShowHide Related Items >><<
CWBHF Charlotte's Web
$0.00 /

+ (+0.00%)

12/09/19 Compass Point
Charlotte's Web initiated with a Buy at Compass Point
11/07/19 Cantor Fitzgerald
Cantor Fitzgerald expects industry consolidation in consumer CBD wellness trend
11/07/19 Cantor Fitzgerald
Charlotte's Web initiated with a Neutral at Cantor Fitzgerald
09/25/19 Piper Sandler
CV Sciences, Charlotte's Web offer most upside on CBD catalysts, says Piper
Initiation
Charlotte's Web initiated with a Buy at Compass Point » 05:34
12/09/19
12/09
05:34
12/09/19
05:34
CWBHF

Charlotte's Web

$0.00 /

+ (+0.00%)

Compass Point initiated…

Compass Point initiated coverage of Charlotte's Web Holdings with a Buy rating and C$15.91 price target.

ShowHide Related Items >><<
CWBHF Charlotte's Web
$0.00 /

+ (+0.00%)

11/07/19 Cantor Fitzgerald
Cantor Fitzgerald expects industry consolidation in consumer CBD wellness trend
11/07/19 Cantor Fitzgerald
Charlotte's Web initiated with a Neutral at Cantor Fitzgerald
09/25/19 Piper Sandler
CV Sciences, Charlotte's Web offer most upside on CBD catalysts, says Piper
08/13/19 Piper Sandler
Charlotte's Web initiated with an Overweight at Piper Jaffray
Initiation
Cantor Fitzgerald expects industry consolidation in consumer CBD wellness trend » 19:11
11/07/19
11/07
19:11
11/07/19
19:11
YCBD

cbdMD

$4.00 /

+0.1 (+2.56%)

, CWBHF

Charlotte's Web

$0.00 /

+ (+0.00%)

, CVSI

CV Sciences

$0.00 /

+ (+0.00%)

Cantor Fitzgerald analyst…

Cantor Fitzgerald analyst Pablo Zuanic initiated CV Sciences (CVSI) with an Overweight rating, price target of $4.20 along with Charlotte's Web (CWBHF) and cbdMD (YCBD) at Neutral with respective price targets of $14.50 and $3.40 as part of his broader sector note on Consumer CBD. The analyst says the industry has risen 6-times in two years, reaching $4B in retail sales, and may reach as high as $25B over the next 5 years. Zuanic contends that while it is currently fragmented, the greater adoption of CBD products at big box retailers will likely lead to industry consolidation, helping the more established brands. In the short term however, the analyst still points to the lack of clear FDA guidelines on CBD sales, adding that near term catalysts on the industry are "to the downside".

ShowHide Related Items >><<
YCBD cbdMD
$4.00 /

+0.1 (+2.56%)

11/07/19 Cantor Fitzgerald
cbdMD initiated with a Neutral at Cantor Fitzgerald
09/10/19 Benchmark
cbdMD initiated with a Speculative Buy at Benchmark
CWBHF Charlotte's Web
$0.00 /

+ (+0.00%)

11/07/19 Cantor Fitzgerald
Charlotte's Web initiated with a Neutral at Cantor Fitzgerald
09/25/19 Piper Sandler
CV Sciences, Charlotte's Web offer most upside on CBD catalysts, says Piper
08/13/19 Piper Sandler
Charlotte's Web initiated with an Overweight at Piper Jaffray
08/12/19 Piper Sandler
Charlotte's Web initiated with an Overweight at Piper Jaffray
CVSI CV Sciences
$0.00 /

+ (+0.00%)

11/07/19 Cantor Fitzgerald
CV Sciences initiated with an Overweight at Cantor Fitzgerald
11/07/19 Cantor Fitzgerald
CV Sciences initiated with an Overweight at Cantor Fitzgerald
11/05/19 BofA
BofA says Mexico cannabis legalization 'still in play' in 2020 after extension
10/10/19 Stifel
Hexo miss further damages cannabis industry credibility, says Stifel
Initiation
Charlotte's Web initiated with a Neutral at Cantor Fitzgerald » 16:17
11/07/19
11/07
16:17
11/07/19
16:17
CWBHF

Charlotte's Web

$0.00 /

+ (+0.00%)

Cantor Fitzgerald analyst…

Cantor Fitzgerald analyst Pablo Zuanic initiated coverage of Charlotte's Web with a Neutral rating and $14.50 price target.

ShowHide Related Items >><<
CWBHF Charlotte's Web
$0.00 /

+ (+0.00%)

09/25/19 Piper Sandler
CV Sciences, Charlotte's Web offer most upside on CBD catalysts, says Piper
08/13/19 Piper Sandler
Charlotte's Web initiated with an Overweight at Piper Jaffray
08/12/19 Piper Sandler
Charlotte's Web initiated with an Overweight at Piper Jaffray
04/24/19 Benchmark
Charlotte's Web initiated with a Buy at Benchmark

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.